News search
 About the CNIC 6 Jul 2022 Through this lifelong honour, new EMBO Members and Associate Members are recognized for their outstanding achievements in the life sciences |
 About the CNIC 29 Jun 2021 Over one million European cancer patients suffer from side effects to chemotherapy |
 About the CNIC 10 May 2021 Dr. Torres is a member of the European Molecular Biology Organization (EMBO). Dr. Miguel Torres’s scientific research focuses on the regulation of embryonic development and the formation and regeneration of organs. |
 About the CNIC 23 Dec 2020 The project will investigate the role of clonal hematopoiesis—the formation of mutated hematopoietic stem-cell clones promoted by anti-cancer therapies—in the development of atherosclerosis and associated cardiovascular disease |
 About the CNIC 15 Dec 2020 The BioClotAD project, coordinated by CNIC scientist Dr Marta Cortés Canteli, has been selected by the EU Joint Programme – Neurodegenerative Disease Research (JPND) |
 Research 9 Oct 2020 CNIC scientists have defined the unique ability if metoprolol to protect the heart during a heart attack |
 |
 About the CNIC 12 Dec 2019 Professor Jacob Fog Bentzon from Aarhus University and the CNIC receives 2 M euros from the European Research Council for a ground-breaking research project on atherosclerosis – one of the most frequent causes of death in the world |
 About the CNIC 18 Sep 2019 Dra. Ivana Nikolić studies the role of T cells in the development of diseases associated with obesity |
 About the CNIC 12 Jun 2019 EMBO promotes excellence in scientific research, and one of its major goals is to support talented researchers at all stages of their careers |
- ‹ previous
- 3 of 5
- next ›
